- en: <!--yml
  id: totrans-0
  prefs: []
  type: TYPE_NORMAL
  zh: <!--yml
- en: 'category: 未分类'
  id: totrans-1
  prefs: []
  type: TYPE_NORMAL
  zh: 'category: 未分类'
- en: 'date: 2024-09-08 19:03:44'
  id: totrans-2
  prefs: []
  type: TYPE_NORMAL
  zh: 日期：2024-09-08 19:03:44
- en: -->
  id: totrans-3
  prefs: []
  type: TYPE_NORMAL
  zh: -->
- en: An LLM-based Knowledge Synthesis and Scientific Reasoning Framework for Biomedical
    Discovery
  id: totrans-4
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: 一种基于LLM的知识综合与科学推理框架用于生物医学发现
- en: 来源：[https://ar5iv.labs.arxiv.org/html/2406.18626](https://ar5iv.labs.arxiv.org/html/2406.18626)
  id: totrans-5
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
  zh: 来源：[https://ar5iv.labs.arxiv.org/html/2406.18626](https://ar5iv.labs.arxiv.org/html/2406.18626)
- en: Oskar Wysocki^(1,2), Magdalena Wysocka², Danilo S. Carvalho², Alex Bogatu²,
  id: totrans-6
  prefs: []
  type: TYPE_NORMAL
  zh: Oskar Wysocki^(1,2), Magdalena Wysocka², Danilo S. Carvalho², Alex Bogatu²,
- en: Danilo Gusicuma¹, Maxime Delmas¹, Harriet Unsworth², André Freitas^(1,2,3)
  id: totrans-7
  prefs: []
  type: TYPE_NORMAL
  zh: Danilo Gusicuma¹, Maxime Delmas¹, Harriet Unsworth², André Freitas^(1,2,3)
- en: ¹Idiap Research Institute, Switzerland
  id: totrans-8
  prefs: []
  type: TYPE_NORMAL
  zh: ¹Idiap 研究所，瑞士
- en: ²National Biomarker Centre, CRUK-MI, Univ. of Manchester, United Kingdom
  id: totrans-9
  prefs: []
  type: TYPE_NORMAL
  zh: ²国家生物标志物中心，CRUK-MI，曼彻斯特大学，英国
- en: ³Department of Computer Science, Univ. of Manchester, United Kingdom
  id: totrans-10
  prefs: []
  type: TYPE_NORMAL
  zh: ³计算机科学系，曼彻斯特大学，英国
- en: 'Correspondence: firstname.lastname@idiap.ch¹firstname.lastname@manchester.ac.uk²'
  id: totrans-11
  prefs: []
  type: TYPE_NORMAL
  zh: 通讯：firstname.lastname@idiap.ch¹firstname.lastname@manchester.ac.uk²
- en: Abstract
  id: totrans-12
  prefs:
  - PREF_H6
  type: TYPE_NORMAL
  zh: 摘要
- en: We present BioLunar, developed using the Lunar framework, as a tool for supporting
    biological analyses, with a particular emphasis on molecular-level evidence enrichment
    for biomarker discovery in oncology. The platform integrates Large Language Models
    (LLMs) to facilitate complex scientific reasoning across distributed evidence
    spaces, enhancing the capability for harmonizing and reasoning over heterogeneous
    data sources. Demonstrating its utility in cancer research, BioLunar leverages
    modular design, reusable data access and data analysis components, and a low-code
    user interface, enabling researchers of all programming levels to construct LLM-enabled
    scientific workflows. By facilitating automatic scientific discovery and inference
    from heterogeneous evidence, BioLunar exemplifies the potential of the integration
    between LLMs, specialised databases and biomedical tools to support expert-level
    knowledge synthesis and discovery.
  id: totrans-13
  prefs: []
  type: TYPE_NORMAL
  zh: 我们展示了BioLunar，使用Lunar框架开发，作为支持生物分析的工具，特别强调用于肿瘤学中生物标志物发现的分子级证据丰富。该平台集成了大语言模型（LLMs），以促进跨分布式证据空间的复杂科学推理，增强了在异质数据源之间协调和推理的能力。通过在癌症研究中的应用，BioLunar利用模块化设计、可重用的数据访问和数据分析组件，以及低代码用户界面，使所有编程水平的研究人员能够构建LLM支持的科学工作流程。通过促进自动化科学发现和从异质证据中推理，BioLunar体现了LLMs、专业数据库和生物医学工具之间集成的潜力，以支持专家级的知识综合和发现。
- en: 1 Introduction
  id: totrans-14
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 1 引言
- en: Contemporary biomedical discovery represents a prototypical instance of complex
    scientific reasoning, which requires the coordination of controlled in-vivo/in-silico
    interventions, complex multi-step data analysis pipelines and the interpretation
    of the results under the light of previous evidence (available in different curated
    databases and in the literature) Paananen and Fortino ([2019](#bib.bib7)); Nicholson
    and Greene ([2020](#bib.bib6)). This intricacy emerges out of the inherent complexity
    of biological mechanisms underlying organism responses, which are defined by a
    network of multi-scale inter-dependencies Bogdan et al. ([2021](#bib.bib2)). While
    more granular data is being generated by the evolution of instruments, assays
    and methods, and the parallel abundance of experimental interventions Dryden-Palmer
    et al. ([2020](#bib.bib4)), there a practical barrier for integrating and cohering
    this evidence space into a specific context of analysis.
  id: totrans-15
  prefs: []
  type: TYPE_NORMAL
  zh: 现代生物医学发现代表了复杂科学推理的典型实例，这需要协调受控的体内/体外干预、复杂的多步骤数据分析流程，并在之前的证据（存在于不同的策划数据库和文献中）基础上解释结果（Paananen
    和 Fortino ([2019](#bib.bib7)); Nicholson 和 Greene ([2020](#bib.bib6))）。这种复杂性源于生物机制的固有复杂性，这些机制通过多尺度相互依赖的网络定义了有机体的反应（Bogdan
    et al. ([2021](#bib.bib2))）。虽然通过仪器、检测方法和技术的演进以及实验干预的并行丰富生成了更细粒度的数据（Dryden-Palmer
    et al. ([2020](#bib.bib4))），但将这些证据空间整合到具体分析上下文中仍存在实际障碍。
- en: 'Within biomedical discovery, the language interpretation capabilities of Large
    Language Models (LLMs) can provide an integrative framework for harmonising and
    reasoning over distributed evidence spaces and tools, systematising and lowering
    the barriers to access and reason over multiple structured databases, textual
    bases such as PubMed, enriching the background knowledge through specialised ontologies
    and serving as interfaces to external analytical tools (e.g. mechanistic/perturbation
    models, gene enrichment models, etc). In this context, LLMs can serve as a linguistic
    analytical layer which can reduce the syntactic impedance across diverse functional
    components: once an adapter to an external component is built it can be integrated
    and reused in different contexts, creating a monotonic increase of functional
    components. Complementarily, from a Biomedical-NLP perspective, in order to address
    real-world problems, LLMs need to be complemented with mechanisms which can deliver
    contextual control (e.g. via Retrieval Augmented Generation: RAG: access the relevant
    background knowledge and facts) and perform the analytical tasks which are integral
    to contemporary biomedical inference (’toolforming’).'
  id: totrans-16
  prefs: []
  type: TYPE_NORMAL
  zh: 在生物医学发现中，大型语言模型（LLMs）的语言解释能力可以提供一个整合框架，用于协调和推理分布式证据空间和工具，系统化并降低访问和推理多个结构化数据库、如PubMed文本库的门槛，通过专业本体丰富背景知识，并作为外部分析工具的接口（例如机制/扰动模型、基因富集模型等）。在这种背景下，LLMs可以作为一个语言分析层，减少不同功能组件之间的语法阻抗：一旦建立了外部组件的适配器，它可以在不同的环境中集成和重用，从而实现功能组件的单调增加。补充地，从生物医学NLP的角度，为了解决实际问题，LLMs需要与能够提供上下文控制的机制（例如通过检索增强生成：RAG：访问相关背景知识和事实）以及执行当代生物医学推断（‘工具形成’）所需的分析任务的机制相结合。
- en: Emerging LLM-focused coordination frameworks such as LangChain¹¹1[https://python.langchain.com](https://python.langchain.com),
    Flowise²²2[https://github.com/FlowiseAI/Flowise](https://github.com/FlowiseAI/Flowise)
    and Lunar³³3[https://lunarbase.ai](https://lunarbase.ai) provide the capabilities
    to deliver a composition of functional components, some of them under a low-code/no-code
    use environment, using the abstraction of workflows. While there are general-purpose
    coordination frameworks, there is a lack of specialised components for addressing
    biomedical analyses.
  id: totrans-17
  prefs: []
  type: TYPE_NORMAL
  zh: 新兴的专注于LLM的协调框架，如LangChain¹¹1[https://python.langchain.com](https://python.langchain.com)、Flowise²²2[https://github.com/FlowiseAI/Flowise](https://github.com/FlowiseAI/Flowise)和Lunar³³3[https://lunarbase.ai](https://lunarbase.ai)
    提供了交付功能组件组合的能力，其中一些在低代码/无代码使用环境下，通过工作流抽象来实现。虽然有通用的协调框架，但在解决生物医学分析方面仍缺乏专业组件。
- en: In this paper we demonstrate BioLunar, a suite of components developed over
    the Lunar environment to support biological analyses. We demonstrate the key functionalities
    of the platform contextualised within a real-use case in the context of molecular-level
    evidence enrichment for biomarker discovery in oncology.
  id: totrans-18
  prefs: []
  type: TYPE_NORMAL
  zh: 在本文中，我们展示了BioLunar，这是一个在Lunar环境中开发的一系列组件，用于支持生物分析。我们在分子水平证据富集的真实用例背景下，展示了该平台的关键功能，用于癌症生物标志物发现。
- en: 2 BioLunar
  id: totrans-19
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 2 BioLunar
- en: '![Refer to caption](img/a775b583471cc50768f8f5718937c128.png)'
  id: totrans-20
  prefs: []
  type: TYPE_IMG
  zh: '![参考说明](img/a775b583471cc50768f8f5718937c128.png)'
- en: 'Figure 1: BioLunar interface. An exemplary workflow of Gene Enrichment with
    an input gene set, knowledge base query and LLM interpretation components.'
  id: totrans-21
  prefs: []
  type: TYPE_NORMAL
  zh: 图1：BioLunar界面。一个基因富集的示例工作流，包括输入基因集、知识库查询和LLM解释组件。
- en: BioLunar enables the creation of LLM-based biomedical scientific workflows using
    software components with standardised APIs. A workflow is composed of components
    and subworkflows connected through input-output relationships, and are capable
    of handling multiple inputs. In the user interface, components are clustered according
    to their function (see Fig.[1](#S2.F1 "Figure 1 ‣ 2 BioLunar ‣ An LLM-based Knowledge
    Synthesis and Scientific Reasoning Framework for Biomedical Discovery")). Creating
    a workflow does not require programming knowledge since components are predefined
    and merely require data inputs or parameter settings. However, for users who wish
    to write custom code, ’Python Coder’ and ’R Coder’ components are provided, enabling
    the definition of custom methods. These custom components can be saved and subsequently
    accessed in the ’Custom’ group tab.
  id: totrans-22
  prefs: []
  type: TYPE_NORMAL
  zh: BioLunar 允许使用具有标准化 API 的软件组件创建基于 LLM 的生物医学科学工作流。一个工作流由通过输入输出关系连接的组件和子工作流组成，并且能够处理多个输入。在用户界面中，组件根据其功能进行分组（见图
    [1](#S2.F1 "Figure 1 ‣ 2 BioLunar ‣ An LLM-based Knowledge Synthesis and Scientific
    Reasoning Framework for Biomedical Discovery")）。创建工作流不需要编程知识，因为组件是预定义的，只需数据输入或参数设置即可。然而，对于希望编写自定义代码的用户，提供了‘Python
    Coder’和‘R Coder’组件，以便定义自定义方法。这些自定义组件可以保存并随后在‘Custom’组选项卡中访问。
- en: In the paper we describe an exemplar biomedical workflow designed to integrate
    evidence and infer conclusions from bioinformatics pipeline results. Specifically,
    the biomedical workflow queries expert knowledge bases (KBs) that continuously
    compile clinical, experimental, and population genetic study outcomes, aligning
    them with assertions relevant to the significance of the observed gene or variant.
    It then employs Natural Language Inference (NLI) (via LLM) to integrate and harmonise
    the evidence space and interpreting the results, culminating in a comprehensive
    summary for the entire gene set input. This interpretation takes into account
    the bioanalytical context supplied by the user.
  id: totrans-23
  prefs: []
  type: TYPE_NORMAL
  zh: 在本文中，我们描述了一个示例生物医学工作流，旨在整合证据并从生物信息学管道结果中推断结论。具体而言，该生物医学工作流查询持续汇编临床、实验和人群遗传研究结果的专家知识库（KBs），并将其与观察到的基因或变体的相关性断言对齐。然后，它使用自然语言推理（NLI）（通过
    LLM）来整合和协调证据空间并解释结果，最终形成整个基因集合输入的综合总结。这种解释考虑了用户提供的生物分析背景。
- en: 2.1 Exemplar Workflow
  id: totrans-24
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 2.1 示例工作流
- en: Next-generation sequencing (NGS) assays play a pivotal role in the precise characterisation
    of tumours and patients in experimental cancer treatments. NGS findings are essential
    to guide the design of novel biomarkers and cancer treatments. Nevertheless, the
    clinical elucidation of NGS findings subsequent to initial bioinformatics analysis
    often requires time-consuming manual analysis procedures which are vulnerable
    to errors. The interpretation of molecular signatures that are typically yielded
    by genome-scale experiments are often supported by pathway-centric approaches
    through which mechanistic insights can be gained by pointing at a set of biological
    processes. Moreover, gene and variant enrichment benefits from heterogeneous curated
    data sources which pose challenges to seamless integration. Furthermore, there
    are different levels of supporting evidence and therefore prioritising conclusions
    is crucial. Automating evidence interpretation, knowledge synthesis and leveraging
    evidence-rich gene set reports are fundamental for addressing the challenges in
    precision oncology and the discovery of new biomarkers.
  id: totrans-25
  prefs: []
  type: TYPE_NORMAL
  zh: 下一代测序（NGS）检测在实验性癌症治疗中对肿瘤和患者的精确表征起着关键作用。NGS 结果对指导新型生物标志物和癌症治疗的设计至关重要。然而，NGS 结果在初步生物信息学分析之后的临床阐释通常需要耗时的手动分析程序，这些程序容易出现错误。分子特征的解释通常依赖于以通路为中心的方法，通过这些方法可以通过指向一组生物过程来获得机制性见解。此外，基因和变体富集受益于异质的策划数据源，这对无缝集成提出了挑战。此外，支持证据有不同的层次，因此优先考虑结论至关重要。自动化证据解释、知识综合和利用丰富证据的基因集合报告对解决精准肿瘤学和新生物标志物发现中的挑战至关重要。
- en: 2.2 User interface
  id: totrans-26
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 2.2 用户界面
- en: 'The user interface facilitates an agile workflow construction by enabling users
    to select and arrange components via drag-and-drop from functionally grouped categories,
    such as, i.a.: ’Prompt Query’ featuring NLI components, ’Knowledge Bases’ components,
    ’Extractors’ for retrieving files from zip archives or extracting text and tables
    from PDF files, and ’Coders’, which allow for the creation of custom components
    using Python or R scripts.'
  id: totrans-27
  prefs: []
  type: TYPE_NORMAL
  zh: 用户界面通过允许用户从功能分组的类别中拖放选择和排列组件，从而促进了敏捷工作流的构建，例如：’Prompt Query’中包含NLI组件，’Knowledge
    Bases’组件，’Extractors’用于从zip档案中检索文件或从PDF文件中提取文本和表格，以及’Coders’，允许使用Python或R脚本创建自定义组件。
- en: Components allow for individual execution, edition, or configuration adjustment
    via a visual interface. Workflows can be executed, saved, or shared. Each component
    has designated input and output capabilities, enabling seamless integration where
    the output from one can directly feed into another. Users have the flexibility
    to manually input values if no direct connection is established. Additionally,
    a component’s output can feed into multiple components. The system’s architecture
    supports effortless expansion, adding branches and components without affecting
    the existing workflow, thus facilitating scalable customization to meet changing
    requirements. The user interface with an example of a workflow is presented in
    Fig.[1](#S2.F1 "Figure 1 ‣ 2 BioLunar ‣ An LLM-based Knowledge Synthesis and Scientific
    Reasoning Framework for Biomedical Discovery") and in demo video [https://youtu.be/Hc6pAA_5Xu8](https://youtu.be/Hc6pAA_5Xu8).
  id: totrans-28
  prefs: []
  type: TYPE_NORMAL
  zh: 组件允许通过可视化界面进行单独执行、编辑或配置调整。工作流可以被执行、保存或共享。每个组件都有指定的输入和输出能力，使得输出可以直接传递给其他组件。用户可以在没有直接连接的情况下手动输入值。此外，一个组件的输出可以传递给多个组件。系统的架构支持轻松扩展，可以在不影响现有工作流的情况下添加分支和组件，从而实现可扩展的定制以满足不断变化的需求。示例工作流的用户界面展示在图[1](#S2.F1
    "Figure 1 ‣ 2 BioLunar ‣ An LLM-based Knowledge Synthesis and Scientific Reasoning
    Framework for Biomedical Discovery")中，演示视频可见于[https://youtu.be/Hc6pAA_5Xu8](https://youtu.be/Hc6pAA_5Xu8)。
- en: 2.3 Knowledge bases
  id: totrans-29
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 2.3 知识库
- en: The current framework integrates a diverse set of knowledge bases which are
    relevant for precision oncology. To identify gene mutations as biomarkers for
    cancer diagnosis, prognosis, and drug response, we integrated CIViC⁴⁴4[https://civicdb.org](https://civicdb.org)
    and OncoKB⁵⁵5[https://www.oncokb.org](https://www.oncokb.org). CIViC provides
    molecular profiles (MPs) of genes, each linked to clinical evidence, with a molecular
    score indicating evidence quality, assessed by human annotators. The Gene Ontology⁶⁶6[https://geneontology.org](https://geneontology.org)
    (GO) offered gene function insights, and the Human Protein Atlas⁷⁷7[https://www.proteinatlas.org](https://www.proteinatlas.org)
    supplied a list of potential drug targets and transcription factors. We employed
    COSMIC⁸⁸8[https://cancer.sanger.ac.uk/cosmic](https://cancer.sanger.ac.uk/cosmic)
    for somatic mutation impacts in cancer, the largest resource in this field. Our
    analysis also included KEGG⁹⁹9[https://www.kegg.jp/kegg/](https://www.kegg.jp/kegg/),
    Reactome^(10)^(10)10[https://reactome.org](https://reactome.org), and WikiPathways^(11)^(11)11[https://www.wikipathways.org](https://www.wikipathways.org)
    for pathway information, enriching our investigation with scientific literature
    via PubMed’s API ^(12)^(12)12[https://pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov).
  id: totrans-30
  prefs: []
  type: TYPE_NORMAL
  zh: 当前框架整合了一系列与精准肿瘤学相关的知识库。为了识别作为癌症诊断、预后和药物反应生物标志物的基因突变，我们整合了CIViC⁴⁴4[https://civicdb.org](https://civicdb.org)和OncoKB⁵⁵5[https://www.oncokb.org](https://www.oncokb.org)。CIViC提供了基因的分子特征（MPs），每个特征都与临床证据相关联，具有指示证据质量的分子评分，由人工注释者评估。基因本体论⁶⁶6[https://geneontology.org](https://geneontology.org)（GO）提供了基因功能的见解，人类蛋白质图谱⁷⁷7[https://www.proteinatlas.org](https://www.proteinatlas.org)提供了潜在药物靶点和转录因子的列表。我们使用COSMIC⁸⁸8[https://cancer.sanger.ac.uk/cosmic](https://cancer.sanger.ac.uk/cosmic)来研究癌症中的体细胞突变影响，这是该领域最大资源。我们的分析还包括KEGG⁹⁹9[https://www.kegg.jp/kegg/](https://www.kegg.jp/kegg/)、Reactome^(10)^(10)10[https://reactome.org](https://reactome.org)和WikiPathways^(11)^(11)11[https://www.wikipathways.org](https://www.wikipathways.org)的通路信息，通过PubMed的API
    ^(12)^(12)12[https://pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov)丰富了我们的调查。
- en: In the following subsections, we showcase examples of components, subworkflows,
    and workflows constructed using the BioLunar framework, motivated by the biomarker
    discovery/precision oncology themes.
  id: totrans-31
  prefs: []
  type: TYPE_NORMAL
  zh: 在接下来的子章节中，我们展示了使用BioLunar框架构建的组件、子工作流和工作流的示例，这些示例受生物标志物发现/精准肿瘤学主题的启发。
- en: 2.4 Construction and reuse of specialised prompts
  id: totrans-32
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 2.4 特殊提示的构建与重用
- en: BioLunar employs standard LLM interfaces, allowing the use of different models
    according to users’ preferences. The prompt components allows for the composition
    of specialised prompt chains which can be later reused, defining a pragmatic pathway
    for specialised Natural Language Inference (NLI) via prompt decomposition/composition.
    This approach allows for the creation of reasoning chains that combines user’s
    instructions with the results of database queries and analyses from specialised
    tools within the context of the study. An instantiated example of the Azure Open
    AI prompt is described in Fig.[1](#S2.F1 "Figure 1 ‣ 2 BioLunar ‣ An LLM-based
    Knowledge Synthesis and Scientific Reasoning Framework for Biomedical Discovery").
  id: totrans-33
  prefs: []
  type: TYPE_NORMAL
  zh: BioLunar 使用标准的 LLM 接口，允许根据用户的偏好使用不同的模型。提示组件允许组成特殊的提示链，这些链可以被后续重用，定义了通过提示分解/组合进行的实用路径，用于专门的自然语言推理（NLI）。这一方法允许创建推理链，将用户的指令与数据库查询结果及来自特定工具的分析结合在研究背景中。图中的一个
    Azure Open AI 提示的实例见图。[1](#S2.F1 "图 1 ‣ 2 BioLunar ‣ 基于 LLM 的知识综合和科学推理框架用于生物医学发现")。
- en: 2.5 Subworkflow component
  id: totrans-34
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 2.5 子工作流组件
- en: The subworkflow component enables the reuse of an existing workflow within another
    workflow, functioning as a component with specified inputs and outputs. This feature
    simplifies the composition of more complex workflows and avoids the repetition
    of defining identical steps for the same task. Subworkflows can be selected like
    other components from the left panel in the interface, offering access to all
    available workflows for easy integration. Examples of subworkflows are presented
    in Fig.[2](#S2.F2 "Figure 2 ‣ 2.5 Subworkflow component ‣ 2 BioLunar ‣ An LLM-based
    Knowledge Synthesis and Scientific Reasoning Framework for Biomedical Discovery"),[3](#S2.F3
    "Figure 3 ‣ 2.5 Subworkflow component ‣ 2 BioLunar ‣ An LLM-based Knowledge Synthesis
    and Scientific Reasoning Framework for Biomedical Discovery").
  id: totrans-35
  prefs: []
  type: TYPE_NORMAL
  zh: 子工作流组件使得可以在另一个工作流中重用现有的工作流，作为具有特定输入和输出的组件。这一功能简化了更复杂工作流的构建，避免了为同一任务重复定义相同步骤。子工作流可以像其他组件一样从界面左侧面板中选择，提供对所有可用工作流的访问，便于集成。子工作流的示例见图。[2](#S2.F2
    "图 2 ‣ 2.5 子工作流组件 ‣ 2 BioLunar ‣ 基于 LLM 的知识综合和科学推理框架用于生物医学发现"),[3](#S2.F3 "图 3
    ‣ 2.5 子工作流组件 ‣ 2 BioLunar ‣ 基于 LLM 的知识综合和科学推理框架用于生物医学发现")。
- en: '![Refer to caption](img/be816f0363a842a53874b8ad83696220.png)'
  id: totrans-36
  prefs: []
  type: TYPE_IMG
  zh: '![参见标题](img/be816f0363a842a53874b8ad83696220.png)'
- en: 'Figure 2: A) Gene Enrichment workflow - uses the gprofiler API to access i.a.
    Gene Ontology, KEGG, WikiPathways, Reactome; B) Human Protein Atlas workflow.
    Compares and interprets the input and reference gene sets.'
  id: totrans-37
  prefs: []
  type: TYPE_NORMAL
  zh: 图 2：A) 基因富集工作流 - 使用 gprofiler API 访问如基因本体、KEGG、WikiPathways、Reactome 等；B) 人类蛋白质图谱工作流。比较和解释输入和参考基因集。
- en: '![Refer to caption](img/a50082ed8622b91217b97224ee207c89.png)'
  id: totrans-38
  prefs: []
  type: TYPE_IMG
  zh: '![参见标题](img/a50082ed8622b91217b97224ee207c89.png)'
- en: 'Figure 3: CIVIC evidence analysis workflow. prompt-based NLI components are
    fed by both the results and context of the analysis in order to produce relevant
    evidence-based conclusions.'
  id: totrans-39
  prefs: []
  type: TYPE_NORMAL
  zh: 图 3：CIVIC 证据分析工作流。基于提示的自然语言推理（NLI）组件通过分析的结果和背景进行供给，以产生相关的基于证据的结论。
- en: 2.6 Gene Enrichment subworkflow
  id: totrans-40
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 2.6 基因富集子工作流
- en: One example of a specialised subworkflow is the Gene Enrichment subworkflow
    (Fig.[1](#S2.F1 "Figure 1 ‣ 2 BioLunar ‣ An LLM-based Knowledge Synthesis and
    Scientific Reasoning Framework for Biomedical Discovery"),[2](#S2.F2 "Figure 2
    ‣ 2.5 Subworkflow component ‣ 2 BioLunar ‣ An LLM-based Knowledge Synthesis and
    Scientific Reasoning Framework for Biomedical Discovery")A) begins with uploading
    the targeted gene sets. Then a component accesses a specific KB — such as Gene
    Ontology, KEGG, Reactome, or WikiPathways—defined by the user, using gprofiler
    API^(13)^(13)13[https://biit.cs.ut.ee/gprofiler/page/apis](https://biit.cs.ut.ee/gprofiler/page/apis).
    This component identifies gene groups with a statistically significant overlap
    with the input gene set, according to a Fisher’s test, and calculates p-values,
    recall, and precision. The user then specifies a variable to rank these groups
    and selects the top N for further analysis. The output includes both a interpretation
    performed by an NLI component (through LLM) and a table featuring the names, descriptions,
    and statistics of the top N selected groups.
  id: totrans-41
  prefs: []
  type: TYPE_NORMAL
  zh: 一个专门的子工作流的例子是基因富集子工作流（图。[1](#S2.F1 "图 1 ‣ 2 BioLunar ‣ 基于 LLM 的知识综合与科学推理框架用于生物医学发现"),[2](#S2.F2
    "图 2 ‣ 2.5 子工作流组件 ‣ 2 BioLunar ‣ 基于 LLM 的知识综合与科学推理框架用于生物医学发现")A），其开始于上传目标基因集。然后，一个组件使用用户定义的特定知识库——如基因本体、KEGG、Reactome
    或 WikiPathways——通过 gprofiler API^(13)^(13)13[https://biit.cs.ut.ee/gprofiler/page/apis](https://biit.cs.ut.ee/gprofiler/page/apis)。该组件根据
    Fisher 检验识别与输入基因集具有统计学显著重叠的基因组，并计算 p 值、召回率和精确度。用户接着指定一个变量来对这些基因组进行排名，并选择前 N 个进行进一步分析。输出包括由
    NLI 组件（通过 LLM）进行的解释和一个包含前 N 个选择组的名称、描述和统计数据的表格。
- en: 2.7 Human Protein Atlas subworkflow
  id: totrans-42
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 2.7 人类蛋白质图谱子工作流
- en: In the Human Protein Atlas subworkflow, given a gene set, an associated external
    KB is queried by selecting ‘Transcription factors’ from the HPA database using
    a dedicated query-database connector. A reusable component, ’Analyze overlap’,
    then identifies genes that overlap and calculates relevant statistics. Similarly
    to the Gene Enrichment subworkflow, the results are interpreted by an prompt-based
    NLI component and presented alongside a table summarising the findings (Fig.[2](#S2.F2
    "Figure 2 ‣ 2.5 Subworkflow component ‣ 2 BioLunar ‣ An LLM-based Knowledge Synthesis
    and Scientific Reasoning Framework for Biomedical Discovery")B,[A.7](#A1.F7 "Figure
    A.7 ‣ Appendix A Appendix ‣ An LLM-based Knowledge Synthesis and Scientific Reasoning
    Framework for Biomedical Discovery")).
  id: totrans-43
  prefs: []
  type: TYPE_NORMAL
  zh: 在人类蛋白质图谱子工作流中，给定一个基因集，通过使用专用的查询数据库连接器从 HPA 数据库中选择“转录因子”来查询相关的外部知识库。一个可重用的组件“分析重叠”随后识别重叠的基因并计算相关统计数据。与基因富集子工作流类似，结果由基于提示的
    NLI 组件进行解释，并与总结发现的表格一起呈现（图。[2](#S2.F2 "图 2 ‣ 2.5 子工作流组件 ‣ 2 BioLunar ‣ 基于 LLM
    的知识综合与科学推理框架用于生物医学发现")B,[A.7](#A1.F7 "图 A.7 ‣ 附录 A ‣ 基于 LLM 的知识综合与科学推理框架用于生物医学发现")）。
- en: 2.8 CIVIC subworkflow
  id: totrans-44
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 2.8 CIVIC 子工作流
- en: This subworkflow exemplifies a more complex composition of components (Fig.[3](#S2.F3
    "Figure 3 ‣ 2.5 Subworkflow component ‣ 2 BioLunar ‣ An LLM-based Knowledge Synthesis
    and Scientific Reasoning Framework for Biomedical Discovery")). This subworkflow
    initiates by querying the CIVIC database for input genes, yielding, among other
    things, gene descriptions in clinical contexts, and their variants and molecular
    profiles (MPs), which are essential for the final interpretation. Additionally,
    users specify the analysis context, including aspects such as cancer types or
    subtypes, treatments, populations, etc. Initially, gene descriptions are analysed
    by a prompt-based NLI component within this defined context. Subsequently, MPs
    scored below a predefined threshold (set at a MP score of 10) are tagged as less
    known, reflecting lower scientific evidence and ranking by CIVIC annotators. The
    evidence supporting these lesser-known MPs is then interpreted by a prompt-based
    NLI component, considering the broader analysis context. Conversely, evidence
    from well-known MPs, scoring above 10, undergoes a similar interpretation process.
  id: totrans-45
  prefs: []
  type: TYPE_NORMAL
  zh: 这个子工作流示例展示了组件的更复杂组合（图[3](#S2.F3 "图 3 ‣ 2.5 子工作流组件 ‣ 2 BioLunar ‣ 基于LLM的知识综合与科学推理框架用于生物医学发现")）。该子工作流通过查询CIVIC数据库的输入基因启动，生成包括基因在临床背景下的描述、变异及分子特征（MPs），这些对最终解释至关重要。此外，用户指定分析背景，包括癌症类型或亚型、治疗方法、群体等方面。最初，基因描述在定义的背景下由基于提示的NLI组件进行分析。随后，MPs的得分低于预设阈值（设置为MP得分10）的被标记为较少了解，反映出较低的科学证据和CIVIC注释员的排名。这些较少了解的MPs的证据随后由基于提示的NLI组件进行解释，考虑到更广泛的分析背景。相反，来自得分高于10的知名MPs的证据经历类似的解释过程。
- en: For genes without identified MPs in CIVIC, a sequence of components perform
    further evidence retrieval from PubMed. An NLI module generates context-based
    keywords for PubMed queries, which are combined with the names of genes lacking
    MPs. A ’PubMed search’ component then retrieves $N$ publications, including metadata,
    citation counts and MeSH terms (used later for context alignment validation).
    The abstracts of these publications are interpreted by an NLI module in the context
    of the analysis.
  id: totrans-46
  prefs: []
  type: TYPE_NORMAL
  zh: 对于在CIVIC中没有识别的MPs的基因，一系列组件会从PubMed中进一步检索证据。NLI模块为PubMed查询生成基于上下文的关键词，这些关键词与缺少MPs的基因名称结合在一起。然后，'PubMed搜索'组件检索$N$篇文献，包括元数据、引用次数和MeSH术语（稍后用于上下文对齐验证）。这些文献的摘要在分析背景下由NLI模块进行解释。
- en: All clinical evidence interpretations are then succinctly summarised by via
    a prompt component, taking into account the context of the analysis. These interpretations,
    along with tabular results, constitute the output.
  id: totrans-47
  prefs: []
  type: TYPE_NORMAL
  zh: 所有临床证据解释都会通过一个提示组件进行简洁总结，考虑到分析的背景。这些解释连同表格结果一起构成最终输出。
- en: 2.9 Bioworkflow - comprehensive analysis for a set of genes.
  id: totrans-48
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 2.9 生物工作流 - 一组基因的综合分析。
- en: The exemplar bioworkflow composes multiple subworkflows (Fig.[4](#S2.F4 "Figure
    4 ‣ 2.9 Bioworkflow - comprehensive analysis for a set of genes. ‣ 2 BioLunar
    ‣ An LLM-based Knowledge Synthesis and Scientific Reasoning Framework for Biomedical
    Discovery")), each dedicated to a specific multi-step and specialised task, which
    are typically defined by the composition of heterogeneous components, most commonly
    connectors and query instance components to specialised databases (e.g. CIVIC,
    HPA, PubMed, OncoKB), external specialised analytical tools (toolformers for gene
    enrichment analysis) and chains of specialised interpretation prompts (e.g. selection,
    filtering, extraction, summarisation). This setup forms a comprehensive workflow
    which exemplifies the close dialogue between LLMs and genomic analysis, encompassing
    gene enrichment, comparison with reference gene sets, and access to evidence within
    an experimental medicine setting. Additionally, it queries PubMed publications
    within the CIVIC component to seek evidence for molecular profiles not yet described.
    Its componentised architecture facilitates the extensibility of the workflow with
    new sources, prompts and external tools. Conclusions drawn from each subworkflow
    are interpreted within the analysis context, being integrated in a comprehensive
    summary. All findings are compiled in a report, exported as a PDF file.
  id: totrans-49
  prefs: []
  type: TYPE_NORMAL
  zh: 示例生物工作流由多个子工作流组成（图[4](#S2.F4 "Figure 4 ‣ 2.9 Bioworkflow - comprehensive analysis
    for a set of genes. ‣ 2 BioLunar ‣ An LLM-based Knowledge Synthesis and Scientific
    Reasoning Framework for Biomedical Discovery")），每个子工作流专注于特定的多步骤和专业任务，这些任务通常由异质组件的组合定义，最常见的是连接器和查询实例组件，用于与专业数据库（例如
    CIVIC、HPA、PubMed、OncoKB）、外部专业分析工具（用于基因富集分析的工具）和专业解释提示链（例如选择、过滤、提取、总结）进行交互。这种设置形成了一个全面的工作流，体现了LLMs与基因组分析之间的紧密对话，包括基因富集、与参考基因集的比较以及在实验医学环境中的证据获取。此外，它在CIVIC组件中查询PubMed出版物，以寻找尚未描述的分子特征的证据。其组件化架构便于通过新来源、提示和外部工具扩展工作流。每个子工作流得出的结论在分析上下文中进行解释，并在综合总结中整合。所有发现都汇编成报告，并导出为PDF文件。
- en: '![Refer to caption](img/344009c5d827dc59263c0aabaf0a2d17.png)'
  id: totrans-50
  prefs: []
  type: TYPE_IMG
  zh: '![参见说明](img/344009c5d827dc59263c0aabaf0a2d17.png)'
- en: 'Figure 4: Diagram of the Bioworkflow.'
  id: totrans-51
  prefs: []
  type: TYPE_NORMAL
  zh: '图 4: 生物工作流图示。'
- en: 2.10 Software description
  id: totrans-52
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 2.10 软件描述
- en: BioLunar uses the LunarVerse backend for its operations. LunarVerse is downloaded
    and installed by the setup script included with the demonstration code. Some of
    its components need user specific configuration to work, such as private API keys,
    which are defined in a configuration file indicated in the setup instructions.
    LunarVerse is distributed under a open software license. The workflow can also
    be operated via a graphical interface (LunarFlow)
  id: totrans-53
  prefs: []
  type: TYPE_NORMAL
  zh: BioLunar 使用 LunarVerse 后端进行操作。LunarVerse 通过演示代码中附带的设置脚本进行下载和安装。其某些组件需要用户特定的配置，例如私有
    API 密钥，这些配置在设置说明中指定的配置文件中定义。LunarVerse 采用开放软件许可证分发。该工作流还可以通过图形界面（LunarFlow）进行操作。
- en: 'Running a workflow can be done in two ways: i) directly, by calling the LunarVerse
    engine on a specified workflow descriptor file; ii) through the Web interface,
    by pressing the “Run” button.'
  id: totrans-54
  prefs: []
  type: TYPE_NORMAL
  zh: 运行工作流可以通过两种方式完成：i) 直接调用指定工作流描述文件上的 LunarVerse 引擎；ii) 通过 Web 界面，点击“运行”按钮。
- en: The first way is the default one in the demonstration code. It returns a copy
    of the workflow descriptor, with all component output fields filled, which is
    then used to extract and filter the desired outputs, based on the component labels.
    It is also the best way to automate multiple workflow runs and to integrate their
    outputs into other systems.The supporting code is available at [https://github.com/neuro-symbolic-ai/lunar-bioverse-demo](https://github.com/neuro-symbolic-ai/lunar-bioverse-demo).
  id: totrans-55
  prefs: []
  type: TYPE_NORMAL
  zh: 第一种方式是演示代码中的默认方式。它返回一个工作流描述的副本，所有组件输出字段已填充，然后用来提取和过滤所需的输出，基于组件标签。这也是自动化多个工作流运行和将其输出集成到其他系统中的最佳方式。支持代码可在
    [https://github.com/neuro-symbolic-ai/lunar-bioverse-demo](https://github.com/neuro-symbolic-ai/lunar-bioverse-demo)
    获得。
- en: 2.11 Report
  id: totrans-56
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 2.11 报告
- en: The Bioworkflow, as outlined in point [2.9](#S2.SS9 "2.9 Bioworkflow - comprehensive
    analysis for a set of genes. ‣ 2 BioLunar ‣ An LLM-based Knowledge Synthesis and
    Scientific Reasoning Framework for Biomedical Discovery"), generates a report
    in PDF (Fig.[5](#S2.F5 "Figure 5 ‣ 2.11 Report ‣ 2 BioLunar ‣ An LLM-based Knowledge
    Synthesis and Scientific Reasoning Framework for Biomedical Discovery")) format
    that begins by outlining the context of the study, analysis details, dates, and
    software versions at the top. The report is enhanced with hyperlinks for easy
    navigation to specific sections.
  id: totrans-57
  prefs: []
  type: TYPE_NORMAL
  zh: Bioworkflow，如[2.9](#S2.SS9 "2.9 Bioworkflow - 针对一组基因的综合分析 ‣ 2 BioLunar ‣ 基于LLM的知识综合与科学推理框架用于生物医学发现")所述，以PDF格式生成报告（图[5](#S2.F5
    "图 5 ‣ 2.11 报告 ‣ 2 BioLunar ‣ 基于LLM的知识综合与科学推理框架用于生物医学发现")），报告开头概述了研究背景、分析细节、日期和软件版本。报告还通过超链接增强了导航到特定部分的便利性。
- en: A "General Statistics" table provides a comprehensive overview of key metrics
    aggregated from all components, aiming to consolidate information for each gene
    throughout the analysis, with hyperlinks directing to the report sections where
    this information originates.
  id: totrans-58
  prefs: []
  type: TYPE_NORMAL
  zh: “通用统计”表格提供了从所有组件汇总的关键指标的全面概述，旨在整合分析过程中每个基因的信息，带有指向信息来源报告部分的超链接。
- en: Subsequent sections categorise genes into various tables based on biological
    aspects and the KBs consulted. These include Molecular Function for genes sharing
    ontologies, drug target checks based on the Human Protein Atlas, assessments of
    cancer-related genes, Pathway Analysis and Mapping via WikiPathways, and classification
    of gene alterations by clinical relevance. By correlating genes with known functional
    information, the workflow identifies statistically significant enriched terms
    and summarizes these findings using LLM, which also furnishes evidence.
  id: totrans-59
  prefs: []
  type: TYPE_NORMAL
  zh: 随后的部分根据生物学方面和咨询的KBs将基因分类到不同的表格中。这些表格包括共享本体的分子功能、基于人类蛋白质图谱的药物靶点检查、癌症相关基因评估、通过WikiPathways进行的途径分析和映射，以及按临床相关性分类的基因变异。通过将基因与已知功能信息相关联，该工作流识别出统计上显著的富集术语，并使用LLM总结这些发现，同时提供证据。
- en: LLM interprets each table, offering textual conclusions relevant to the analysis
    context. A final summary, crafted using LLM, synthesizes all results within the
    given context. Importantly, all LLM interpretations are grounded in concrete evidence,
    with sources cited alongside the narrative. This approach underscores the rigor
    of the analysis by highlighting distinct sources that substantiate the relevance
    of each gene and variant.
  id: totrans-60
  prefs: []
  type: TYPE_NORMAL
  zh: LLM解释每个表格，提供与分析背景相关的文本结论。最终总结由LLM编制，综合了所有结果并置于给定背景中。重要的是，所有LLM解释都基于具体证据，叙述旁边有引用来源。这种方法通过突出支撑每个基因和变异相关性的不同来源，强调了分析的严谨性。
- en: '![Refer to caption](img/1714240408549296249d194aaf7f19d2.png)'
  id: totrans-61
  prefs: []
  type: TYPE_IMG
  zh: '![参见说明](img/1714240408549296249d194aaf7f19d2.png)'
- en: 'Figure 5: The BioLunar report’s overview, produced by Bioworkflow.'
  id: totrans-62
  prefs: []
  type: TYPE_NORMAL
  zh: 图 5：由Bioworkflow生成的BioLunar报告概览。
- en: 3 Case study
  id: totrans-63
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 3 案例研究
- en: To demonstrate the capabilities of the Bioworkflow, we analyzed outputs in two
    different scenarios, each producing a distinct set of genes from separate bioinformatics
    analyses. We entered these gene sets along with their analysis contexts into the
    Bioworkflow and executed it. Subsequently, we qualitatively assessed the output
    reports (see Fig.[A.8](#A1.F8 "Figure A.8 ‣ Appendix A Appendix ‣ An LLM-based
    Knowledge Synthesis and Scientific Reasoning Framework for Biomedical Discovery"),[A.9](#A1.F9
    "Figure A.9 ‣ Appendix A Appendix ‣ An LLM-based Knowledge Synthesis and Scientific
    Reasoning Framework for Biomedical Discovery")), considering both the statistical
    data and the interpretations provided by the prompt-based NLI modules.
  id: totrans-64
  prefs: []
  type: TYPE_NORMAL
  zh: 为了展示Bioworkflow的能力，我们在两种不同的场景中分析了输出，每种场景产生了一组不同的基因，这些基因来自独立的生物信息学分析。我们将这些基因集及其分析背景输入到Bioworkflow中并执行。随后，我们对输出报告进行了定性评估（见图[A.8](#A1.F8
    "图 A.8 ‣ 附录 A 附录 ‣ 基于LLM的知识综合与科学推理框架用于生物医学发现"),[A.9](#A1.F9 "图 A.9 ‣ 附录 A 附录 ‣
    基于LLM的知识综合与科学推理框架用于生物医学发现")），考虑了统计数据和基于提示的NLI模块提供的解释。
- en: In Scenario 1, the user aims to explore the unique molecular characteristics
    of HER2-low breast cancer to determine if it constitutes a distinct category within
    breast cancer types, where the input genes are ERBB2, ESR1, PIK3CA, CBFB, SF3B.
    The report shows genomic alterations and genomic signatures that were identified,
    including ERBB2 amplification, mutations in PIK3CA and ESR1, which are important
    biomarkers in the selection of breast cancer treatment. For the remaining two
    genes, evidence was found confirming that these are new, significantly mutated
    genes for which there is pre-clinical evidence of actionability in clinical practice.
  id: totrans-65
  prefs: []
  type: TYPE_NORMAL
  zh: 在场景1中，用户的目标是探索HER2低表达乳腺癌的独特分子特征，以确定它是否构成乳腺癌类型中的一个独立类别，其中输入基因为ERBB2, ESR1, PIK3CA,
    CBFB, SF3B。报告展示了识别出的基因组变化和基因组特征，包括ERBB2扩增、PIK3CA和ESR1的突变，这些都是选择乳腺癌治疗的重要生物标志物。对于剩余的两个基因，发现了证据确认这些是新发现的、显著突变的基因，且有临床前证据表明其在临床实践中具有可操作性。
- en: In Scenario 2, the user aims to discover new genes that could lead to more accurate
    breast cancer diagnoses, enhancing treatment strategies and addressing the disease’s
    complexity. His numerical analysis resulted in a set of genes (DIXDC1, DUSP6,
    PDK4, CXCL12, IRF7, ITGA7, NEK2, NR3C1) that require investigation. The report
    informs that none of the genes is an oncogene (confirmation according to OncoKB),
    two of the genes are potential drug targets and one is FDA approved drug targets.
    According to the KEGG-based enrichment analysis, these genes were mainly enriched
    through several signaling pathways including tumor necrosis factor (TNF) signaling
    pathway. Using LLMs in conjunction with a PubMed search component, papers were
    searched in PubMed that describe various gene variants and the genes have been
    indicated as prospective biomarkers associated with breast cancer.
  id: totrans-66
  prefs: []
  type: TYPE_NORMAL
  zh: 在场景2中，用户的目标是发现可能导致更准确乳腺癌诊断的新基因，从而改进治疗策略并解决疾病的复杂性。他的数值分析结果得出了一组需要进一步研究的基因（DIXDC1,
    DUSP6, PDK4, CXCL12, IRF7, ITGA7, NEK2, NR3C1）。报告指出，这些基因中没有一个是癌基因（根据OncoKB的确认），其中两个基因是潜在的药物靶点，而一个是FDA批准的药物靶点。根据KEGG基础的富集分析，这些基因主要通过包括肿瘤坏死因子（TNF）信号通路在内的几个信号通路富集。通过将LLMs与PubMed搜索组件结合使用，搜索了PubMed中描述各种基因变体的论文，并指出这些基因作为与乳腺癌相关的潜在生物标志物。
- en: Note that in scenario 2, for genes lacking molecular profiles in the KB, a search
    in PubMed was conducted. This approach enables the workflow to automatically uncover
    and search for non-obvious and previously unknown relationships. Essentially,
    if a gene is absent from the database, it suggests that its relevance is relatively
    novel and not yet documented. Therefore, seeking out the most recent publications
    that describe this gene within the analysis context represents a significant advantage,
    provided by the workflow that integrates various components.
  id: totrans-67
  prefs: []
  type: TYPE_NORMAL
  zh: 注意，在场景2中，对于KB中缺乏分子谱的基因，进行了PubMed搜索。这种方法使得工作流程能够自动发现和搜索不明显的、之前未知的关系。本质上，如果一个基因在数据库中缺失，意味着其相关性相对较新，尚未记录。因此，在分析背景下寻找描述该基因的最新出版物，代表了工作流程所提供的重要优势，该流程集成了各种组件。
- en: 4 Related Work
  id: totrans-68
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 4 相关工作
- en: Bioinformatics Pipelines Over the past decade, three scientific workflow management
    systems such as Galaxy gal ([2022](#bib.bib1)), Snakemake Köster and Rahmann ([2012](#bib.bib5)),
    and Nextflow Di Tommaso et al. ([2017](#bib.bib3)), have been instrumental to
    bioinformaticians to systematise their complex analytical processes. Nextflow
    targets bioinformaticians and facilitates gene enrichment analysis, annotate biological
    sequences, and perform gene expression analysis by including modules supported
    by various bioinformatics tools. These workflow systems are currently centred
    around the composition of specialised bioinformatics software, configuration parameters
    and supporting datasets, facilitating reuse and reproducibility. In contrast,
    this paper explores the concept on using LLMs within a specialised workflow environment
    to support the interpretation and integration of multiple analytical processes.
  id: totrans-69
  prefs: []
  type: TYPE_NORMAL
  zh: 生物信息学流程 在过去十年中，像Galaxy gal ([2022](#bib.bib1))、Snakemake Köster 和 Rahmann ([2012](#bib.bib5))
    以及 Nextflow Di Tommaso et al. ([2017](#bib.bib3)) 等三个科学工作流程管理系统，对于生物信息学家系统化他们复杂的分析过程发挥了重要作用。Nextflow
    主要针对生物信息学家，促进基因富集分析、注释生物序列和进行基因表达分析，包含了由各种生物信息学工具支持的模块。这些工作流程系统目前围绕专业生物信息学软件、配置参数和支持数据集的组成进行，促进了重复使用和可重现性。相比之下，本文探讨了在专业工作流程环境中使用LLM以支持多重分析过程的解释和整合的概念。
- en: 5 Conclusion
  id: totrans-70
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 5 结论
- en: In this paper we provided a demonstration of a scientific workflow based on
    LLMs to support specialised gene analyses using oncology and gene enrichment as
    a driving motivational scenario. The framework is built using the Lunar framework
    and allows for the composition of specialised analytical workflows, integrating
    external databases (Retrieval Augmented Generation), external tools (ToolFormers)
    and contextualised chains of LLM-based interpretation. The paper highlights that
    a workflow environment with specialised components for RAG, ToolFormers and a
    set of specialised prompts-based Natural Language Inference can serve as the foundation
    for streamlining and automating complex analytical process within a biomedical
    setting. . We showcase analytical applications within the biomedical domain, particularly
    in oncology, constructively progressing towards more complex gene analysis workflows.
    The developed bioworkflow demonstrates the LLMs can be instrumental in enabling
    a complex end-to-end highly-specialised analytical workflow, in a reproducible
    manner, supporting the integration of heterogeneous evidence, synthesising conclusions
    and while simultaneously documenting and linking to the data sources within a
    comprehensive output report. The proposed workflow is based on a low-code paradigm
    that enables domain experts, regardless of their programming skills, to construct
    and scientific workflows enabled by generaqtive AI amethods.
  id: totrans-71
  prefs: []
  type: TYPE_NORMAL
  zh: 本文展示了一个基于LLM的科学工作流程示例，以支持使用肿瘤学和基因富集作为驱动动机的专业基因分析。该框架使用Lunar框架构建，允许构建专业的分析工作流程，集成外部数据库（检索增强生成）、外部工具（ToolFormers）和上下文化的LLM基础解释链。文章强调，具有RAG、ToolFormers和一套基于自然语言推理的专业提示的工作流程环境，可以作为简化和自动化生物医学环境中复杂分析过程的基础。我们展示了生物医学领域内，特别是在肿瘤学中的分析应用，逐步推进更复杂的基因分析工作流程。开发的生物工作流程表明，LLM可以在启用复杂的端到端高度专业化分析工作流程中发挥重要作用，以可重复的方式支持异质证据的整合、合成结论，同时记录并链接到数据源，形成全面的输出报告。所提出的工作流程基于低代码范式，使领域专家无论编程技能如何，都能构建由生成性AI方法支持的科学工作流程。
- en: Limitations
  id: totrans-72
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 局限性
- en: •
  id: totrans-73
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: The current demonstration uses external LLM-based APIs but can be adapted to
    open source LLM models.
  id: totrans-74
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 当前的演示使用了外部LLM基础的API，但可以适配开源LLM模型。
- en: •
  id: totrans-75
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: The LLM-based inferences require a critical supporting quantitative evaluation
    and hallucinations are possible. The current workflow is motivated by a hypothesis
    generation process, which is fully human supervised and does not have direct clinical
    applications.
  id: totrans-76
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 基于LLM的推理需要重要的定量评估支持，并且可能会出现虚假信息。目前的工作流程是由假设生成过程驱动的，该过程完全由人工监督，并且没有直接的临床应用。
- en: Acknowledgements
  id: totrans-77
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 致谢
- en: This work was partially funded by The Ark foundation, by the European Union’s
    Horizon 2020 research and innovation program (grant no. 965397) through the Cancer
    Core Europe DART project, and by the Manchester Experimental Cancer Medicine Centre
    and the NIHR Manchester Biomedical Research Centre.
  id: totrans-78
  prefs: []
  type: TYPE_NORMAL
  zh: 本研究部分由 The Ark 基金会、欧盟的 Horizon 2020 研究与创新计划（资助编号 965397）通过癌症核心欧洲 DART 项目，以及曼彻斯特实验癌症医学中心和
    NIHR 曼彻斯特生物医学研究中心资助。
- en: References
  id: totrans-79
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 参考文献
- en: 'gal (2022) 2022. The galaxy platform for accessible, reproducible and collaborative
    biomedical analyses: 2022 update. *Nucleic Acids Research*, 50(W1):W345–W351.'
  id: totrans-80
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: gal (2022) 2022年。用于可访问、可重复和协作的生物医学分析的 Galaxy 平台：2022年更新。*核酸研究*，50(W1)：W345–W351。
- en: Bogdan et al. (2021) Paul Bogdan, Gustavo Caetano-Anollés, Anna Jolles, Hyunju
    Kim, James Morris, Cheryl A Murphy, Catherine Royer, Edward H Snell, Adam Steinbrenner,
    and Nicholas Strausfeld. 2021. [Biological Networks across Scales—The Theoretical
    and Empirical Foundations for Time-Varying Complex Networks that Connect Structure
    and Function across Levels of Biological Organization](https://doi.org/10.1093/icb/icab069).
    *Integrative and Comparative Biology*, 61(6):1991–2010.
  id: totrans-81
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: Bogdan 等 (2021) Paul Bogdan, Gustavo Caetano-Anollés, Anna Jolles, Hyunju Kim,
    James Morris, Cheryl A Murphy, Catherine Royer, Edward H Snell, Adam Steinbrenner
    和 Nicholas Strausfeld。2021年。[跨尺度的生物网络——连接生物组织各层次结构与功能的时变复杂网络的理论与实证基础](https://doi.org/10.1093/icb/icab069)。*综合与比较生物学*，61(6)：1991–2010。
- en: Di Tommaso et al. (2017) Paolo Di Tommaso, Maria Chatzou, Evan W Floden, Pablo Prieto
    Barja, Emilio Palumbo, and Cedric Notredame. 2017. Nextflow enables reproducible
    computational workflows. *Nature biotechnology*, 35(4):316–319.
  id: totrans-82
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: Di Tommaso 等 (2017) Paolo Di Tommaso, Maria Chatzou, Evan W Floden, Pablo Prieto
    Barja, Emilio Palumbo 和 Cedric Notredame。2017年。Nextflow 实现可重复的计算工作流。*自然生物技术*，35(4)：316–319。
- en: 'Dryden-Palmer et al. (2020) K.D. Dryden-Palmer, C.S. Parshuram, and W.B. Berta.
    2020. [Context, complexity and process in the implementation of evidence-based
    innovation: a realist informed review](https://doi.org/10.1186/s12913-020-4935-y).
    *BMC Health Services Research*, 20(81):1472–6963.'
  id: totrans-83
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: Dryden-Palmer 等 (2020) K.D. Dryden-Palmer, C.S. Parshuram 和 W.B. Berta。2020年。[基于证据的创新实施中的背景、复杂性和过程：一项现实主义的综述](https://doi.org/10.1186/s12913-020-4935-y)。*BMC
    健康服务研究*，20(81)：1472–6963。
- en: Köster and Rahmann (2012) Johannes Köster and Sven Rahmann. 2012. Snakemake—a
    scalable bioinformatics workflow engine. *Bioinformatics*, 28(19):2520–2522.
  id: totrans-84
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: Köster 和 Rahmann (2012) Johannes Köster 和 Sven Rahmann。2012年。Snakemake——一个可扩展的生物信息学工作流引擎。*生物信息学*，28(19)：2520–2522。
- en: Nicholson and Greene (2020) David N. Nicholson and Casey S. Greene. 2020. [Constructing
    knowledge graphs and their biomedical applications](https://doi.org/https://doi.org/10.1016/j.csbj.2020.05.017).
    *Computational and Structural Biotechnology Journal*, 18:1414–1428.
  id: totrans-85
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: Nicholson 和 Greene (2020) David N. Nicholson 和 Casey S. Greene。2020年。[构建知识图谱及其生物医学应用](https://doi.org/https://doi.org/10.1016/j.csbj.2020.05.017)。*计算与结构生物技术期刊*，18：1414–1428。
- en: Paananen and Fortino (2019) Jussi Paananen and Vittorio Fortino. 2019. [An omics
    perspective on drug target discovery platforms](https://doi.org/10.1093/bib/bbz122).
    *Briefings in Bioinformatics*, 21(6):1937–1953.
  id: totrans-86
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: Paananen 和 Fortino (2019) Jussi Paananen 和 Vittorio Fortino。2019年。[药物靶点发现平台的组学视角](https://doi.org/10.1093/bib/bbz122)。*生物信息学简报*，21(6)：1937–1953。
- en: Appendix A Appendix
  id: totrans-87
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 附录 A 附录
- en: '![Refer to caption](img/0d65879c11f269312b5084456742df3c.png)'
  id: totrans-88
  prefs: []
  type: TYPE_IMG
  zh: '![参见图注](img/0d65879c11f269312b5084456742df3c.png)'
- en: 'Figure A.6: User-defined context of the analysis, including aspects like cancer
    types or subtypes, treatments, populations, for Scenario 1 and 2.'
  id: totrans-89
  prefs: []
  type: TYPE_NORMAL
  zh: 图 A.6：分析的用户定义背景，包括癌症类型或亚型、治疗方法、人口等，适用于情景 1 和 2。
- en: '![Refer to caption](img/129d955c842c36a990d9a9691ca5e3e2.png)'
  id: totrans-90
  prefs: []
  type: TYPE_IMG
  zh: '![参见图注](img/129d955c842c36a990d9a9691ca5e3e2.png)'
- en: 'Figure A.7: Human Protein Atlas workflow in the BioLunar interface.'
  id: totrans-91
  prefs: []
  type: TYPE_NORMAL
  zh: 图 A.7：BioLunar 界面中的人类蛋白质图谱工作流。
- en: '![Refer to caption](img/30672df1bda81caf5bd6d431590f5521.png)'
  id: totrans-92
  prefs: []
  type: TYPE_IMG
  zh: '![参见图注](img/30672df1bda81caf5bd6d431590f5521.png)'
- en: 'Figure A.8: The BioLunar report, produced by Bioworkflow for Scenario 1'
  id: totrans-93
  prefs: []
  type: TYPE_NORMAL
  zh: 图 A.8：Bioworkflow 为情景 1 制作的 BioLunar 报告。
- en: '![Refer to caption](img/9d261af58c143f306c3c780971d99fea.png)'
  id: totrans-94
  prefs: []
  type: TYPE_IMG
  zh: '![参见图注](img/9d261af58c143f306c3c780971d99fea.png)'
- en: 'Figure A.9: The BioLunar report, produced by Bioworkflow for Scenario 2.'
  id: totrans-95
  prefs: []
  type: TYPE_NORMAL
  zh: 图 A.9：Bioworkflow 为情景 2 制作的 BioLunar 报告。
